Injective is retesting its previous trading range after giving back part of its recent rally, with traders watching for renewed momentum toward $6. The LI.FI integration also expands Injective’s cross-chain reach across more than 60 networks and 1,000 applications, strengthening liquidity access and its broader DeFi growth outlook.
